by Ursula Tschorn | Apr 6, 2026 | Drug Dictionaries
A drug shortage database for Germany is built on a legally mandated reporting framework that determines what data is available, how current it is, and where the gaps are. Understanding this framework is essential for any pharma professional who wants to turn shortage...
by Ursula Tschorn | Apr 6, 2026 | Drug Pricing
A pharmaceutical data API is the most efficient way to integrate structured drug information — PZN identifiers, pricing, active ingredients, and clinical data — into your own software. Whether you are building a health-tech application, an ERP module, or a clinical...
by Ursula Tschorn | Apr 6, 2026 | Drug Dictionaries
An EU drug authorization database is the single most important research tool for pharmaceutical professionals who need to know which medicines are authorized in which countries. Whether you are sourcing reference products for a generic application, identifying market...
by Ursula Tschorn | Apr 6, 2026 | Drug Pricing
German drug pricing data follows a regulated, multi-stage calculation chain that determines what manufacturers, wholesalers, pharmacies, and patients pay for prescription medicines. Unlike market-driven pricing systems in the United States, Germany uses a...
by Ursula Tschorn | Apr 6, 2026 | Regulatory
A discontinued drugs Germany archive is one of the most overlooked resources in pharmaceutical business development. Every year, dozens of medicinal products are deleted from the German market — and as of March 2026, BfArM lists 562 active shortage entries, many...
